2016 American Transplant Congress

Monday, June 13, 2016

2:42pm-2:54pm

Common Molecular Features of Human Kidney Transplant Rejection Reflect Mechanistic Sharing Between T Cell-Mediated and Antibody-Mediated Rejection.

J. Venner,^1,2 P. Halloran.²

Concurrent Session: Kidney Immune Monitoring 2  •  Ballroom C

2:42pm-2:54pm

Direct IL-33 Stimulation of T Regulatory Cells via Suppression of Tumorigenicity 2 (ST2) Is Required for Effective Control of Alloimmune Responses.

X. Zhang,^1,3 B. Matta,¹ D. Reichenbach,² B. Blazar,² H. Turnquist.¹

Concurrent Session: Regulatory T Cells: Animal Models  •  Room 309

2:42pm-2:54pm

Diversity of Influenza Antibody Repertoire in Transplant Recipients with Natural Influenza Infection.

V. Ferreira, A. Chruscinski, S. Han, A. Humar, D. Kumar.

Concurrent Session: Various Viruses, Vaccines, and SOT  •  Room 306

2:42pm-2:54pm

Early Hospital Readmission Following Pediatric Kidney Transplantation.

E. King, L. Kucirka, M. McAdams-DeMarco, S. Bae, D. Segev.

Concurrent Session: Kidney: Pediatrics  •  Room 311

2:42pm-2:54pm

Fate of Endogenous Alloreactive B Cells in Transplant Tolerance.

J. Chen,¹ J. Yang,¹ A. Akl,¹ Q. Wang,¹ D. Yin,¹ R. Sciammas,² A. Chong.¹

Concurrent Session: B Cells in Rejection and Tolerance: Animal Models  •  Room 310

2:42pm-2:54pm

Fc Receptor Binding Assay for Functional Assessment of HLA Antibodies: Initial Clinical Validation.

E. Woodle, A. Girnita.

Concurrent Session: Identifying Antibodies - Tools of the Trade  •  Ballroom B

2:42pm-2:54pm

Hepatitis E Virus (HEV) Infection Among Kidney Transplant Patients in a Northeast US Center.

M. Lim,¹ S. Kamili,² T. Greene,² A. Tejada-Strop,² J. Drobeniuc,² M. Vanderveen,¹ R. Bloom.¹

Concurrent Session: Viral Hepatitis  •  Ballroom A

2:42pm-2:54pm

Live Donor Champion Program: Time to Redefine Living Liver Donation.

D. Maluf, A. Sites, M. Donovan, J. Wang, E. Lyster, C. Argo.

Concurrent Session: Living Donor Liver Transplantation  •  Room 210

2:42pm-2:54pm

Long-Term Outcomes of ATG versus IL-2 Receptor Antagonist in Low Risk Kidney Transplant Recipients: Donor Factors.

F. Al Ammary, S. Bae, A. Massie, N. Desai, N. Dagher, E. Kraus, A. Wiseman, D. Segev.

Concurrent Session: Kidney: Induction Therapy 1  •  Room 312

2:42pm-2:54pm

Primary Outcome of iWITH: A Multi-Center Clinical Trial of Complete Immunosuppression Withdrawal (ISW) in Stable Pediatric Liver Transplant (LT) Recipients.

S. Feng,¹ J. Bucuvalas,² A. Demetris,³ K. Spain,⁴ S. Kanaparthi,⁵ J. Magee,⁶ G. Mazariegos,³ The iWITH Investigators.⁷

Concurrent Session: Clinical Science: Tolerance: Clinical Studies  •  Room 304